One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience-Reference-Cited by-同舟云学术

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

Published:2012-01 Issue:1 Volume:87 Page:25-33
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Tefferi Ayalew,Lasho Terra L.,Jimma Thitina,Finke Christy M.,Gangat Naseema,Vaidya Rakhee,Begna Kebede H.,Al-Kali Aref,Ketterling Rhett P.,Hanson Curtis A.,Pardanani Animesh

Publisher

Elsevier BV

Subject

General Medicine

Reference53 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

2. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment;Barosi;Leukemia,2008

3. Zwei Falle von Leukamie mit eigenthumlichem Blut- resp. Knochenmarksbefund;Heuck;Arch Pathol Anat Physiol Virchows,1879

4. Some speculations on the myeloproliferative syndromes;Dameshek;Blood,1951

5. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis;Jacobson;Blood,1978

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis;Blood Advances;2024-08-28

2. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Myeloproliferative Neoplasms;Journal of Palliative Medicine;2024-08-20

3. Myelofibrosis and anemia: A German claims data analysis to describe epidemiology and current treatment;European Journal of Haematology;2024-08-05

4. MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients;Annals of Hematology;2024-07-29

5. Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUM;Future Oncology;2024-07-29